药品注册申请号:201044
申请类型:ANDA (仿制药申请)
申请人:MYLAN LABS LTD
申请人全名:MYLAN LABORATORIES LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML No No AP 2017/02/07 2017/02/07 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/03/07 SUPPL-1(补充) Approval Labeling STANDARD
2017/02/07 ORIG-1(原始申请) Approval Not Applicable
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ETOMIDATE 剂型/给药途径:INJECTABLE;INJECTION 规格:2MG/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018227 001 NDA AMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription Yes Yes AP 1982/09/07 HOSPIRA
074593 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 1996/11/04 HIKMA
202360 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 2014/07/18 ZYDUS PHARMS
204618 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Discontinued No No AP 2014/08/13 AVET LIFESCIENCES
202354 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 2016/02/25 HIKMA
201044 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 2017/02/07 MYLAN LABS LTD
206126 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 2017/02/24 EUGIA PHARMA
209058 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 2017/04/18 GLAND PHARMA LTD
215028 001 ANDA ETOMIDATE ETOMIDATE INJECTABLE;INJECTION 2MG/ML Prescription No No AP 2020/12/18 CAPLIN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database